Related Experiment Video

Updated: Apr 27, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

945

Growth arrest signaling of the Raf/MEK/ERK pathway in cancer

Jong-In Park1

  • 1Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.

Frontiers in Biology
|July 8, 2014
PubMed

Insights

The Raf/MEK/extracellular signal-regulated kinase (ERK) pathway can surprisingly halt cell growth, acting as a tumor suppressor. This review explores how ERK signaling causes growth arrest in various cell types.

Area of Science:

  • Cellular signaling
  • Cancer biology
  • Molecular pathways

Background:

  • The Raf/MEK/extracellular signal-regulated kinase (ERK) pathway is crucial for cell proliferation.
  • Deregulated ERK pathway activation is common in epithelial cancers.
  • Paradoxically, sustained ERK activity can induce cell growth arrest.

Purpose of the Study:

  • To review the mechanisms by which the Raf/MEK/ERK pathway mediates growth arrest.
  • To explore the cell types where this anti-proliferative signaling occurs.
  • To clarify the role of ERK1 and ERK2 in growth arrest.

Main Methods:

  • Literature review of studies on Raf/MEK/ERK signaling.
  • Analysis of research on cell proliferation and growth arrest.
  • Focus on the specific roles of ERK1 and ERK2.

Main Results:

  • The Raf/MEK/ERK pathway exhibits dual roles in cell proliferation and growth arrest.
  • Growth arrest mediated by ERK signaling has physiological significance, including tumor suppression.
  • Understanding the specific mechanisms and cell types involved is still developing.

Conclusions:

  • The Raf/MEK/ERK pathway's role in growth arrest is a significant, yet incompletely understood, biological process.
  • Further research is needed to elucidate the precise mechanisms and cellular contexts of ERK-mediated growth arrest.
  • This pathway holds potential as a tumor suppressive mechanism warranting deeper investigation.
Keywords:
ERK1/2MEK1/2Rafgrowth arrestnon-kinase effectproliferation

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

5.7K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

2.4K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K